Health & Medicine
-
First FDA-Approved Drug for Type 3 Gaucher Neurological Symptoms Targets Ataxia and Cognition
Infilbray (venglustat) crosses the blood-brain barrier to treat the CNS manifestations that enzyme replacement therapy cannot reach.
-
GLP-1s Extend Beyond Weight Loss to Treat Heart Disease and Addiction
New research suggests GLP-1 drugs may help with heart disease, sleep apnea, and addiction, expanding their role beyond diabetes and obesity.
-
Sacituzumab Tirumotecan Boosts Survival in Advanced Gastroesophageal Cancer
The TROP2-targeted antibody-drug conjugate significantly improved overall survival in a phase 3 trial for heavily pretreated patients.
-
FDA approves Novo Nordisk’s Sogroya as first weekly growth hormone for Turner syndrome
The once-weekly injection offers a major convenience boost for children with Turner syndrome, reducing daily shots while maintaining comparable growth rates.
Personal Finance
-
How to Replace a $2,500 Monthly Pension With 401(k) Savings
A father’s company-paid pension highlights the heavy math required for younger workers replacing traditional retirement benefits with 401(k) accounts.
-
How to Pay Down Credit Card Debt Before Holiday Spending Peaks
With U.S. balances at a record $1.29 trillion and average rates near 25%, experts say balance transfers and strict repayment plans are…
-
Small Business Sale Can Trigger Up to 37% Federal Tax, New Data Shows
A typical 2026 small‑business exit faces a combined federal and state tax hit that can exceed a third of the sale price,…
-
Annuity Renewal Traps: How Automatic Rollovers Lock Retirees Into Lower Rates
A 30-day window to move $280,000 closed while the owner waited, triggering a new five-year term with fresh surrender charges and a…
Cancer News
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
Phase 1 data show 87% response and 18-month PFS; pivotal phase 2 met goals but BMS withheld numbers as phase 3 begins.
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
The FDA’s August 2026 approval of iberdomide introduces a new class of cancer drugs for patients with relapsed or refractory multiple myeloma.
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
WASHINGTON, July 7 — A 13-year gap between a mother’s breast cancer diagnosis and her daughter’s own diagnosis has laid bare persistent…
Health News
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
LONDON, July 15 — The shift is stark: a new study from the Indiana University School of Medicine suggests bowel cancer patients…
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
WASHINGTON — A new study suggests that drinking water with meals may trigger a psychological compensation mechanism, leading individuals to eat more.…
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
World News
-
The Black Sea Grain Initiative: A Deal That Collapsed in 2023
ISTANBUL, July 14 — The Black Sea Grain Initiative, a diplomatic arrangement that once allowed over 32 million metric tons of grain…
-
Kenyan families mark two years since 2024 protests with flowers, marches and calls for accountability
Nairobi, June 25 — As Kenya approaches the anniversary of the June 2024 protests, families of the victims are speaking out about…
-
Five Die After Car Hits Parked Truck on Hyderabad Outer Ring Road Near Adibatla
Pedda Amberpet Crash: Five Families Wait for Names as Road Safety Questions Mount Five families are waiting for official word. Police have…
-
Bus Overturns Into Gorge Near Chakri Interchange on Pakistan’s M2 Motorway, Killing 6
A devastating bus accident occurred on July 13, 2025, near the village of Chakri, Pakistan, resulting in the loss of six lives…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Blood Biomarker eMTBR-tau243 Detects Advanced CTE in Living Patients
-
Cemdisiran Cuts Dosing to Four Shots a Year in Myasthenia Gravis
-
AbbVie Bets $2.5 Billion on DISCO’s Bispecific Platform to Expand Oncology Pipeline
-
US Loses Measles Elimination Status as Endemic Transmission Returns After 26 Years
-
Pandemic Disruptions Drove Excess Breast Cancer and Leukaemia Deaths Across 54 Nations
-
How Fed Cuts, Bank Competition and Deposit Insurance Could Crash High-Yield Savings Rates
-
How 401(k) Holders Can Automatically Cut Single-Stock Concentration Risk
-
California’s Financial Literacy Mandate: The 2031 Graduation Requirement Explained
-
Fixed Index Annuities: How Buffer, Floor, and Fee Structures Shift $400,000 Outcomes
-
No Surprises Act arbitration adds $8.39 billion to employer health‑plan costs in 2025























